Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal?

Adrenalectomy for pheochromocytoma is reported with a mortality close to zero in recent studies. The dogma of preoperative fluid and hypotensive drug administrations is widely applied in patients scheduled for pheochromocytoma removal and is assumed to have a beneficial effect on operative outcomes. This paradigm is only based on historical studies of non-standardized practices and criteria for efficacy, with no control group. Pre- and intraoperative hypovolemia have never been demonstrated in patients scheduled for pheochromocytoma removal. Recent improvements in outcome of patients undergoing adrenalectomy for pheochromocytoma could also be the result of improvement in surgical techniques and refinement in anesthetic practices. Whether better knowledge of the disease, efficiency of available intravenous short-acting vasoactive drugs, and careful intraoperative handling of the tumor make it possible to omit preoperative preparation in most patients scheduled for pheochromocytoma removal is presently questionable. We reviewed available literature in this respect.

[1]  Wesley Mcmillian,et al.  Phentolamine continuous infusion in a patient with pheochromocytoma. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[2]  G. Opocher,et al.  Genetics of pheochromocytomas and paragangliomas. , 2010, Best practice & research. Clinical endocrinology & metabolism.

[3]  V. Papademetriou,et al.  Hypertension crisis , 2010, Blood pressure.

[4]  M. Rayan,et al.  Assessment of Coronary Flow Parameters by Transesophageal Echocardiography in Patients with Isolated Coronary Artery Ectasia: Effect of Intravenous Nitroglycerin , 2010, Echocardiography.

[5]  G. Thompson,et al.  Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. , 2010, Urology.

[6]  I. Ure,et al.  Renal tissue damage after experimental pyelonephritis: role of antioxidants and selective cyclooxygenase-2 inhibitors. , 2010, Urology.

[7]  E. Kaplan,et al.  Pheochromocytoma in Pregnancy: A Case Series and Review , 2010, Hypertension.

[8]  N. Shah,et al.  Pheochromocytoma and pregnancy: a rare but dangerous combination. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[9]  G. Kazemier,et al.  Risk Factors for Hemodynamic Instability during Surgery for Pheochromocytoma. , 2010, The Journal of clinical endocrinology and metabolism.

[10]  M. Guerrero,et al.  Clinical spectrum of pheochromocytoma. , 2009, Journal of the American College of Surgeons.

[11]  R. Cavallazzi,et al.  Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: A systematic review of the literature* , 2009, Critical care medicine.

[12]  F. Beuschlein,et al.  Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. , 2009, European journal of endocrinology.

[13]  J. Bertherat,et al.  Increased arterial pressure is not predictive of haemodynamic instability in patients undergoing adrenalectomy for phaeochromocytoma , 2009, Acta anaesthesiologica Scandinavica.

[14]  P. Gosse,et al.  Preparation for surgery of phaeochromocytoma by blockade of α-adrenergic receptors with urapidil: what dose? , 2009, Journal of Human Hypertension.

[15]  T. Sakamoto,et al.  Hypovolemic shock evaluated by sonographic measurement of the inferior vena cava during resuscitation in trauma patients. , 2007, The Journal of trauma.

[16]  D. Torigian,et al.  Rapidly reversible cardiogenic shock as a pheochromocytoma presentation. , 2007, The American journal of medicine.

[17]  A. Toniato,et al.  Is the laparoscopic adrenalectomy for pheochromocytoma the best treatment? , 2007, Surgery.

[18]  A. Tischler,et al.  Pheochromocytoma: recommendations for clinical practice from the First International Symposium , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[19]  C. Nies,et al.  Intraoperative haemodynamic stability in patients with phaeochromocytoma – minimally invasive vs conventional open surgery , 2006, Clinical endocrinology.

[20]  L. Sibal,et al.  Phaeochromocytomas presenting as acute crises after beta blockade therapy , 2006, Clinical endocrinology.

[21]  M. Pinsky,et al.  Esophageal Doppler monitoring predicts fluid responsiveness in critically ill ventilated patients , 2005, Intensive Care Medicine.

[22]  A. Park,et al.  Laparoscopic Curative Resection of Pheochromocytomas , 2005, Annals of surgery.

[23]  G. Lebuffe,et al.  The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas , 2005, Anaesthesia.

[24]  K. Leslie,et al.  For Personal Use. Only Reproduce with Permission from the Lancet , 2022 .

[25]  B. Tavernier,et al.  Systolic pressure variation (Δdown) can guide fluid therapy during pheochromocytoma surgery , 2003, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[26]  B. Mégarbane,et al.  Comparison of cardiac output measured with echocardiographic volumes and aortic Doppler methods during mechanical ventilation , 2003, Intensive Care Medicine.

[27]  J. Farndon,et al.  Efficacy and Safety of Doxazosin for Perioperative Management of Patients with Pheochromocytoma , 2002, World Journal of Surgery.

[28]  M. Cadeddu,et al.  Minimally invasive adrenalectomy for pheochromocytoma during pregnancy. , 2002, Surgical laparoscopy, endoscopy & percutaneous techniques.

[29]  M. Walther,et al.  Biochemical diagnosis of pheochromocytoma: which test is best? , 2002, JAMA.

[30]  R. Poopalalingam,et al.  Rapid preparation of a patient with pheochromocytoma with labetolol and magnesium sulfate , 2001, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[31]  D. Benhamou,et al.  Phenylephrine Added to Prophylactic Ephedrine Infusion during Spinal Anesthesia for Elective Cesarean Section , 2001, Anesthesiology.

[32]  G. Chatellier,et al.  Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. , 2001, The Journal of clinical endocrinology and metabolism.

[33]  C. Sridhar,et al.  Prolonged hypoglycaemia following surgical removal of phaeochromocytoma , 2000, Postgraduate medical journal.

[34]  E F Cook,et al.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[35]  N. Abumrad,et al.  Clinical experience over 48 years with pheochromocytoma. , 1999, Annals of surgery.

[36]  A. Novick,et al.  Successful outcomes in pheochromocytoma surgery in the modern era. , 1999, The Journal of urology.

[37]  M. Goldacre,et al.  Risk factors for cardiovascular death after elective surgery under general anaesthesia. , 1998, British journal of anaesthesia.

[38]  M. Roizen,et al.  Safe and Cost-Effective Preoperative Preparation of Patients with Pheochromocytoma , 1998, Anesthesia and analgesia.

[39]  S. Sirrs,et al.  Anaesthesia for phaeochromocytoma in pregnancy , 1997, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[40]  Carr Aa,et al.  Metyrosine and pheochromocytoma. , 1997, Archives of internal medicine.

[41]  J. A. Friederich,et al.  Sodium Nitroprusside: Twenty Years and Counting , 1995, Anesthesia and analgesia.

[42]  J. S. Goldberg,et al.  Postoperative hypertension: A multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside , 1992, Critical care medicine.

[43]  A. Boutros,et al.  Perioperative management of 63 patients with pheochromocytoma. , 1990, Cleveland Clinic journal of medicine.

[44]  M. Heifetz,et al.  Phaeochromocytoma and severe protracted postoperative hypoglycaemia , 1990, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[45]  M. James,et al.  Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: a review of 17 anaesthetics. , 1989, British journal of anaesthesia.

[46]  R. Freeark,et al.  Plasma catecholamine changes during excision of pheochromocytoma. , 1988, Surgery.

[47]  R. Gray.  Managing critically ill patients with esmolol. An ultra short-acting beta-adrenergic blocker. , 1988, Chest.

[48]  P. Fossati,et al.  Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion. , 1986, Surgery.

[49]  T. K. Hunt,et al.  The effect of alpha-adrenergic blockade on cardiac performance and tissue oxygen delivery during excision of pheochromocytoma. , 1984, Surgery.

[50]  J. Marty,et al.  Anaesthetic management of patients with phaeochromocytoma. , 1984, British journal of anaesthesia.

[51]  L. Cubeddu,et al.  Prazosin and propranolol in preoperative management of pheochromocytoma , 1982, Clinical pharmacology and therapeutics.

[52]  J. Desmonts,et al.  [Alpha-methyl -para-tyrosine in the prolonged treatment of malignant pheochromocytoma and preoperative care of benign pheochromocytoma: preliminary study]. , 1972, Journal d'urologie et de nephrologie.

[53]  L. B. Perry,et al.  The Anesthetic Management of Pheochromocytoma: Effect of Preoperative Adrenergic Blocking Drugs , 1972, Anesthesia and analgesia.

[54]  A. Sjoerdsma,et al.  Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis. , 1968, The Journal of clinical investigation.

[55]  B. Prichard,et al.  Preoperative and operative management of patients with phaeochromocytoma. , 1967, British medical journal.

[56]  T. Waldmann,et al.  Pheochromocytoma: current concepts of diagnosis and treatment. Combined clinical staff conference at the National Institutes of Health. , 1966, Annals of internal medicine.

[57]  A. Goldfien.  Pheochromocytoma: Diagnosis and Anesthetic and Surgical Management , 1963, Anesthesiology.

[58]  S. Brunjes,et al.  PHEOCHROMOCYTOMA: POSTOPERATIVE SHOCK AND BLOOD VOLUME , 1961 .

[59]  F. Finnerty,et al.  The blood volumes and plasma protein during levarterenol-induced hypertension. , 1958, The Journal of clinical investigation.

[60]  J. Thompson,et al.  PHEOCHROMOCYTOMA: SURGICAL AND ANESTHETIC MANAGEMENT , 1954, Anesthesiology.

[61]  D. Nitkin,et al.  A Systematic Review of the Literature , 2010 .

[62]  L. Fleisher,et al.  Anesthetic Implications of Concurrent Diseases , 2010 .

[63]  H. Lim,et al.  Targeting the arterial wall, but what is the target? , 2009, Journal of Human Hypertension.

[64]  J. Dalen.  Aspirin resistance: is it real? Is it clinically significant? , 2007, The American journal of medicine.

[65]  M. Warner,et al.  Perioperative management of pheochromocytoma. , 2002, Journal of cardiothoracic and vascular anesthesia.

[66]  M. Lamy,et al.  Hemodynamic changes and catecholamine release during laparoscopic adrenalectomy for pheochromocytoma. , 1999, Anesthesia and analgesia.

[67]  M. Heifetz,et al.  Phaeochromocytoma and severe protracted postoperative , 1990 .

[68]  G. Lavery,et al.  Histaminoid responses to atracurium, vecuronium and tubocurarine. , 1985, Annales francaises d'anesthesie et de reanimation.

[69]  P. Fossati,et al.  [Dopamine-secreting pheochromocytoma. An unrecognized entity?]. , 1984, Chirurgie; memoires de l'Academie de chirurgie.